M. Inoue et al., High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts, CANCER RES, 61(3), 2001, pp. 950-956
A synthetic peptide corresponding to the human MUC2 tandem repeat unit was
glycosylated in vitro using UDP-GalNAc and extracts of colonic adenocarcino
ma and paired normal mucosa, followed by fractionation of the products by r
everse phase high-performance Liquid chromatography. Several peaks of glyco
peptides with different numbers of GalNAc residues attached were detected.
It is notable that the adenocarcinoma extract was capable of glycosylating
peptides to a much greater extent than was normal mucosa, The levels of mRN
A for N-acetylgalactosaminyltransferases-1, -2, and -3 were determined by r
everse transcription-PCR, Only N-acetylgalactosaminyltransferase-3 mRNA was
expressed at a higher level in the adenocarcinoma than in the normal tissu
e. When the MUC2 tandem repeat peptide was glycosylated with a mixture of t
he normal mucosa extract and recombinant N-acetylgalactosaminyltransferase-
3, larger amounts of glycopeptides with higher contents of GalNAc residues
were produced. The MUC2 tandem repeat peptides glycosylated extensively by
recombinant N-acetylgalactosaminyltransferase-1, -2, or -3 were prepared an
d characterized, Substitution at each Thr residue, as revealed by Edman deg
radation sequencing, in conjunction with evidence obtained on mass spectrom
etry indicated a heterogeneous pattern of site-specific glycosylation withi
n the MUC2 tandem repeat. It was found that maximum numbers of 6, 8, and 11
GalNAc residues were incorporated by N-acetylgalactosaminyltransferases-1,
-2, and -3, respectively, and that only N-acetylgalactosaminyltransferase-
3 could completely glycosylate both consecutive sequences composed of three
and five Thr residues in the MUC2 tandem repeat unit. These results sugges
t that O-glycosylation of the clustered Thr residues is a selective process
controlled by N-acetylgalactosaminyltransferase-3 in the synthesis of clus
tered carbohydrate antigens.